By Amy Harmon / The Bulletin
March 2, 2010
Editor’s note: This is the third in a three-part series that chronicles the initial human trial of an experimental cancer drug. Part I appeared Sunday in The Bulletin, and Part II Monday.
ORLANDO, Fla. — On a sunny afternoon last June, Dr. Keith Flaherty stood before a large room packed with....